Mogroside IV

Overview

Mogroside IV is a pancreatic lipase inhibitor with a IC 50 of 289.09 µg/mL. Mogroside IV inhibits pancreatic lipase in a dose-dependent manner. Mogroside IV can be used in research related to obesity.

Application

Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Lipid Metabolism | Products > Disease Areas > Obesity | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > Lipase

Product Information

• Catalog No.: HY-N6945
• CAS No.: 89590-95-4
• Molecular Formula: C54H92O24
• Molecular Weight: 1125.29
• Purity: 98.57%
• Storage: 4°C, protect from light * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
• Solubility: ≥ 2.5 mg/mL (2.22 mM); Clear solution
• Availability: In-stock

Source

Original product source